5.02

3.28% -0.17

After Hours: 5.03 0.01 +0.20%

Trisalus Life Sciences Inc (TLSI)

Overview News Price History Discussions Forecast

Trisalus Life Sciences Inc stock is traded at $5.02, with a volume of 31,325. It is down -3.28% in the last 24 hours and down -8.73% over the past month. TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

Previous Close:

$5.19

Open:

$5.19

24h Volume:

31,325

Relative Volume:

0.66

Market Cap:

$165.23M

Revenue:

$15.33M

Net Income/Loss:

$-40.19M

P/E Ratio:

-2.865

EPS:

-1.7522

Net Cash Flow:

1W Performance:

-1.76%

1M Performance:

-8.73%

6M Performance:

+18.68%

1Y Performance:

-48.78%

1-Day Range:

$4.98

$5.24

1-Week Range:

$4.66

$5.40

52-Week Range:

$3.50

$10.24

Trisalus Life Sciences Inc Stock (TLSI) Company Profile

Name

Trisalus Life Sciences Inc

Sector

Healthcare (1153)

Industry

Medical Devices (157)

Phone

415 336 8917

Address

6272 WEST 91ST AVENUE, WESTMINSTER

Employee

110

Twitter

Next Earnings Date

Latest SEC Filings

TLSI's Discussions on Twitter

Compare TLSI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TLSI Trisalus Life Sciences Inc	5.02	165.23M	15.33M	-40.19M	0	-1.7522
ABT Abbott Laboratories	133.24	231.09B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	102.86	155.24B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	380.92	144.54B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	83.48	108.82B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	73.68	44.31B	5.54B	4.18B	623.10M	7.00

Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-13-25	Initiated	Lake Street	Buy
Dec-17-24	Initiated	Cantor Fitzgerald	Overweight
Nov-11-24	Initiated	ROTH MKM	Buy
Oct-25-24	Initiated	Northland Capital	Outperform
Sep-16-24	Initiated	Oppenheimer	Outperform
May-30-24	Initiated	Canaccord Genuity	Buy

View All

Trisalus Life Sciences Inc Stock (TLSI) Latest News

May 08, 2025

13,400 Shares in TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Acquired by Renaissance Technologies LLC - Defense World

May 08, 2025

May 02, 2025

Geode Capital Management LLC Purchases 3,710 Shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSI) - Defense World

May 02, 2025

Apr 30, 2025

Northland maintains TriSalus stock with $12.50 target - Investing.com Australia

Apr 30, 2025

Northland maintains TriSalus stock with $12.50 target By Investing.com - Investing.com India

Apr 30, 2025

TLSI Reports Strong Revenue Growth in First Quarter of 2025 | TL - GuruFocus

Apr 30, 2025

TriSalus Life Sciences (TLSI) Secures $22M Investment and Plans Capital Restructuring | TLSI Stock News - GuruFocus

Apr 30, 2025

TriSalus Life Sciences secures $22 million in funding By Investing.com - Investing.com India

Apr 30, 2025

TriSalus Life Sciences secures $22 million in funding - Investing.com

Apr 30, 2025

TriSalus Life Sciences Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results - Business Wire

Apr 30, 2025

Apr 26, 2025

TriSalus Life Sciences files to offer up to 3.34M shares - MSN

Apr 26, 2025

Apr 23, 2025

TriSalus Life Sciences announces board member resignation By Investing.com - Investing.com Canada

Apr 23, 2025

TriSalus Life Sciences announces board member resignation - Investing.com Australia

Apr 23, 2025

Apr 22, 2025

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives $11.56 Average Price Target from Analysts - Defense World

Apr 22, 2025

Apr 15, 2025

TriSalus Life Sciences, Inc. SEC 10-K Report - TradingView

Apr 15, 2025

Apr 10, 2025

VAREX IMAGING (VREX) Moves 16.5% Higher: Will This Strength Last? - Yahoo Finance

Apr 10, 2025

Apr 09, 2025